Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tonsoku-like, DNA repair protein (TONSL) is a scaffold protein critical for genome stability. It forms a complex with MMS22L to support homologous recombination-mediated repair of stalled or collapsed replication forks by promoting RAD51 filament formation on single-stranded DNA. TONSL also functions as a histone reader, recognizing newly synthesized histones (preferentially unmethylated H4K20 and H3.1), and is important for DNA replication, chromatin remodeling, and the maintenance of genomic integrity. It acts as a transcription corepressor and inhibits NF-kappa-B-mediated transcription by retaining NF-kappa-B in the cytoplasm. Mutations or dysfunction in TONSL are associated with cancer susceptibility and specific bone diseases, emphasizing its role in DNA repair and cellular stress responses[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tonsoku-like, DNA repair protein (TONSL).